Stocks and Investing
Stocks and Investing
Thu, August 15, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Jeff Jones Reiterated (avbp) at Buy and Held Target at $35 on, Aug 15th, 2024
Jeff Jones of Oppenheimer, Reiterated "ArriVent BioPharma, Inc." (AVBP) at Buy and Held Target at $35 on, Aug 15th, 2024.
Jeff has made no other calls on AVBP in the last 4 months.
There is 1 other peer that has a rating on AVBP. Out of the 1 peers that are also analyzing AVBP, 0 agree with Jeff's Rating of Hold.
This is the rating of the analyst that currently disagrees with Jeff
- Robert Burns of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $25 on, Thursday, June 6th, 2024
Contributing Sources